Literature DB >> 17471425

Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile.

Marcela Ferres1, Pablo Vial, Claudia Marco, Lia Yanez, Paula Godoy, Constanza Castillo, Brian Hjelle, Iris Delgado, Sang-Joon Lee, Gregory J Mertz.   

Abstract

BACKGROUND: Andes virus (ANDV) infection, which has a case fatality rate of 37% in Chile, often occurs in household clusters and may be transmitted from person to person.
METHODS: To determine the incidence and risk factors for additional household cases, we conducted a prospective study among recent household contacts of persons with hantavirus cardiopulmonary syndrome (HCPS) in Chile, including testing of serum for anti-hantavirus antibodies and blood cells for ANDV RNA by reverse-transcription polymerase chain reaction (RT-PCR).
RESULTS: We enrolled 76 index case patients and 476 household contacts, of whom 16 (3.4%) developed HCPS; 32.6% of 92 cases occurred in household clusters. The risk of HCPS was 17.6% among sex partners of index case patients, versus 1.2% among other household contacts (P<.001). Person-to-person transmission was definite in 3, probable in 9, and possible in 2 of the 16 additional household case patients. We detected ANDV RNA by RT-PCR in peripheral blood cells 5-15 days before the onset of symptoms or the appearance of anti-hantavirus antibodies.
CONCLUSIONS: In recent household contacts of persons with HCPS in Chile, the risk of HCPS was greatest among sex partners. Among the household contacts who developed HCPS, viremia preceded the onset of symptoms and the appearance of anti-hantavirus antibodies by up to 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471425     DOI: 10.1086/516786

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

Review 1.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

2.  Andes virus infections in the rodent reservoir and in humans vary across contrasting landscapes in Chile.

Authors:  Fernando Torres-Pérez; R Eduardo Palma; Brian Hjelle; Marcela Ferrés; Joseph A Cook
Journal:  Infect Genet Evol       Date:  2009-07-24       Impact factor: 3.342

3.  Spatial but not temporal co-divergence of a virus and its mammalian host.

Authors:  Fernando Torres-Pérez; R Eduardo Palma; Brian Hjelle; Edward C Holmes; Joseph A Cook
Journal:  Mol Ecol       Date:  2011-08-31       Impact factor: 6.185

Review 4.  Landscape, Climate and Hantavirus Cardiopulmonary Syndrome Outbreaks.

Authors:  Paula Ribeiro Prist; Paulo Sérgio D Andrea; Jean Paul Metzger
Journal:  Ecohealth       Date:  2017-06-15       Impact factor: 3.184

Review 5.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004-2008.

Authors:  Sabra L Klein; Morgan A Marks; Wei Li; Gregory E Glass; Li-Qun Fang; Jia-Qi Ma; Wu-Chun Cao
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

7.  Knowledge, attitudes, and practices regarding hantavirus disease and acceptance of a vaccine trial in rural communities of southern Chile.

Authors:  Francisca Valdivieso; Claudia Gonzalez; Manuel Najera; Andrea Olea; Analia Cuiza; Ximena Aguilera; Gregory Mertz
Journal:  Hum Vaccin Immunother       Date:  2016-11-10       Impact factor: 3.452

8.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

9.  Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome.

Authors:  Paula Godoy; Delphine Marsac; Elias Stefas; Pablo Ferrer; Nicole D Tischler; Karla Pino; Pablo Ramdohr; Pablo Vial; Pablo D T Valenzuela; Marcela Ferrés; Francisco Veas; Marcelo López-Lastra
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

10.  Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.

Authors:  Jay W Hooper; Anthony M Ferro; Victoria Wahl-Jensen
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.